Company logo
Sector: Healthcare
Industry: Drug Manufacturers—specialty & Generic

Phibro Animal Health Corp - Class A

Ticker - PAHC
Country: US
Exchange: NASDAQ

Monitor Performance using this Dynamic, Always Current, Periodic Table of Investments

Data:

Time:

Alignment:

About Phibro Animal Health Corp - Class A

  • Company Overview
    • PAHC (Patterson Companies, Inc.) is a leading distributor of dental and animal health products and services, primarily operating in North America.
    • The company operates through two main segments: Dental and Animal Health.
  • PAHC (Patterson Companies, Inc.) is a leading distributor of dental and animal health products and services, primarily operating in North America.
  • The company operates through two main segments: Dental and Animal Health.
  • Business Model
    • Patterson’s business model revolves around distribution, delivering a wide range of products to dental and veterinary practitioners.
    • It provides manufacturers with access to a vast customer base while offering healthcare professionals essential supplies and services that enhance their practices.
  • Patterson’s business model revolves around distribution, delivering a wide range of products to dental and veterinary practitioners.
  • It provides manufacturers with access to a vast customer base while offering healthcare professionals essential supplies and services that enhance their practices.
  • Core Products and Services
    • In the Dental segment, core offerings include dental equipment, dental supplies, and software solutions that support practice management.
    • In the Animal Health segment, Patterson supplies veterinary products, pharmaceuticals, and diagnostic equipment.
    • Key brands associated with Patterson include Patterson Dental and Patterson Veterinary.
  • In the Dental segment, core offerings include dental equipment, dental supplies, and software solutions that support practice management.
  • In the Animal Health segment, Patterson supplies veterinary products, pharmaceuticals, and diagnostic equipment.
  • Key brands associated with Patterson include Patterson Dental and Patterson Veterinary.
  • Financial Performance
    • Patterson typically showcases stability in sales due to its extensive customer base and recurring revenue from the sale of consumable products.
    • Financial metrics such as revenue growth, gross margins, and operating income are vital indicators of its operational efficiency and profitability.
  • Patterson typically showcases stability in sales due to its extensive customer base and recurring revenue from the sale of consumable products.
  • Financial metrics such as revenue growth, gross margins, and operating income are vital indicators of its operational efficiency and profitability.
  • Competitive Position
    • Patterson competes with several entities in both the dental and veterinary sectors, including Henry Schein and McKesson, among others.
    • Its competitive advantage lies in its established relationships with healthcare providers, broad distribution network, and comprehensive product portfolio.
    • The company invests in technology and service innovations to differentiate itself and enhance customer loyalty.
  • Patterson competes with several entities in both the dental and veterinary sectors, including Henry Schein and McKesson, among others.
  • Its competitive advantage lies in its established relationships with healthcare providers, broad distribution network, and comprehensive product portfolio.
  • The company invests in technology and service innovations to differentiate itself and enhance customer loyalty.
  • Market Context
    • The dental healthcare market is characterized by steady growth, driven by rising demand for dental services and increased awareness of oral health.
    • The animal health market has seen expansion due to growing pet ownership and increased expenditure on pet health.
    • Regulatory and economic factors can impact profitability, particularly in the pharmaceutical aspects of the business.
  • The dental healthcare market is characterized by steady growth, driven by rising demand for dental services and increased awareness of oral health.
  • The animal health market has seen expansion due to growing pet ownership and increased expenditure on pet health.
  • Regulatory and economic factors can impact profitability, particularly in the pharmaceutical aspects of the business.
  • Risks and Challenges
    • Patterson faces risks from competition, market saturation, and potential disruptions in supply chains that could affect product availability.
    • Technological advancements from competitors may challenge Patterson's market share if the company fails to innovate accordingly.
    • Economic fluctuations could influence spending in the healthcare sector, impacting both dental and veterinary services.
  • Patterson faces risks from competition, market saturation, and potential disruptions in supply chains that could affect product availability.
  • Technological advancements from competitors may challenge Patterson's market share if the company fails to innovate accordingly.
  • Economic fluctuations could influence spending in the healthcare sector, impacting both dental and veterinary services.
    • SWOT ANALYSIS

    SWOT Analysis is a strategic planning tool used to identify and understand the key factors that can impact a business or project. What are the key factors for gaining a competitive market share advantage? Also, what potential threats should we be wary of during our Process?

    STRENGTHS

    • Strong market presence in the health care industry, enhancing brand recognition and customer loyalty.
    • Diverse product portfolio that caters to various segments of the health care market.
    • Efficient operational model that supports cost management and margin improvement.

    WEAKNESSES

    • Dependence on a limited number of key clients, making revenue vulnerable to customer loss.
    • Potential for high operational costs that could impact profitability under economic pressure.

    OPPORTUNITIES

    • Growing demand for specialized health care solutions presents avenues for expansion.
    • Potential for strategic partnerships and acquisitions to enhance product offerings and market reach.

    THREATS

    • Intense competition from established players and new entrants in the health care sector.
    • Regulatory changes and compliance issues that could impose additional costs and operational constraints.

    Please enjoy this free portfolio visualization and monitoring tool. Click Install from the address bar for easy and fast future access.

    Paid accounts can visualize any portfolio or watchlist in this performance visualization… plus a million other cool things — including daily data, sharing custom tables for the assets you care about, industry-leading portfolio backtesting, and full portfolio strategy analytics. Both individual and professional versions are supported.

    Performance Disclosure

    This portfolio is hypothetical.


    This is a historical simulation of the portfolio performance an investor would have obtained had you invested in the same selections at the beginning of the simulation. This report provides information on how the portfolio holdings would have changed and would have performed for a certain period. We have strived to reduce or eliminate potential biases in the process to provide the most accurate assessment of the performance prospects of the strategy. However, it may not be possible for any historical simulation to completely ensure it is free of all biases.


    Please see
    Gold Standard for Portfolio Backtesting and
    Seven Deadly Sins of Portfolio Backtesting
    for a more complete understanding of risks and biases when backtesting portfolio strategies.


    Backtested strategies also run the risk of cherry picking. Cherry Picking is when the author of the backtest has created many variations and is presenting one of the variations that is more favorable. This research was not produced in whole or in part by cherry picking.


    This simulation is based on an account with tax exempt or tax deferred growth. Taxable accounts will have to pay the appropriate taxes for dividends, interest, and capital gains, which will decrease the performance depicted.


    This simulation is not based on actual trading accounts or account composites which may or may not exist for this strategy and may be materially different including worse than the performance illustrated above. Past performance is not necessarily indicative of future performance. Performance results including risk and diversification measures are not guaranteed to persist in the future.


    This historical performance simulation has been adjusted to reflect estimated management fees.


    The suitability of this portfolio strategy requires that you have thoughtfully and accurately completed your investor objectives from your accounts’ Investment Policy Statement. Login


    Diversification strategies alone cannot assure a successful investment outcome. Strategies offering greater diversification also fail to guarantee any reduction in loss of capital.


    Your ability to follow this investment strategy is a risk. Investors often dispose of successful strategies at inopportune times thus turning potentially profitable strategies into losses.


    Portfolio data is taken from sources believed to be accurate, however, there is no warranty or guarantee as to the accuracy or completeness of data and statistical calculations thereupon. Portfolio ThinkTank does not furnish investment advice without an investment advisory agreement.


    The period of time selected for analysis may have a significant bearing on the relative attractiveness of the strategy and the strategy versus another portfolio or benchmark. The author of the strategy controls the default period of time used to analyze performance and from there, users may select any desired period of time from the menu. In general, longer periods, greater diversification and lower concentrations of holdings result in more credible, more persistent performance evaluations.


    If this strategy includes predictions created by our deep learning neural net, there are additional risks that portfolio strategies and their backtested performance may have risks of having the data be overfit and consequently perform better in the backtest than it may in real account performance. We manage these risks regularly and in many ways. However, due to the attention mechanisms in a deep learning neural network, it may not be possible to eliminate these risks. To learn if your portfolio strategy is built using predictions from a neural network or to better understand our mitigation policies, we invite you to start a conversation: hello@gravityinvestments.com